Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 8.31 4.43 0.39 15.01 10.85
Fund with Sales Charge (%) (POP) 2.35 2.48 -0.74 14.37 10.57
NASDAQ Biotechnology Index (%) 1.18 4.88 0.31 15.22 11.33
S&P 500 Index (%) 8.19 9.87 9.23 12.65 7.34
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 34.84 10.53 3.37 15.92 11.12
Fund with Sales Charge (%) (POP) 27.43 8.46 2.20 15.27 10.84
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 34.84 -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28
Fund with Sales Charge (%) (POP) 27.43 -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -3.81 8.31 13.89 1.95 305.07 909.85
Fund with Sales Charge (%) (POP) -9.10 2.35 7.63 -3.65 282.80 854.13
NASDAQ Biotechnology Index (%) -5.32 1.18 15.37 1.57 312.44 1,014.58
S&P 500 Index (%) -8.27 8.19 32.62 55.49 229.18 390.65
Quarter EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 34.84 34.84 35.02 18.00 338.03 949.86
Fund with Sales Charge (%) (POP) 27.43 27.43 27.59 11.51 313.98 891.93
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87

After-Tax Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 6.12 3.11 -1.08 13.56
Fund without Sales Charge (%) (NAV) After Shares Sold 6.63 3.26 0.04 12.31
Fund with Sales Charge (%) (POP) Before Shares Sold 0.27 1.17 -2.19 12.92
Fund with Sales Charge (%) (POP) After Shares Sold 3.00 1.75 -0.81 11.73
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.10 9.12 1.85 14.45
Fund without Sales Charge (%) (NAV) After Shares Sold 22.60 7.99 2.29 13.10
Fund with Sales Charge (%) (POP) Before Shares Sold 24.84 7.08 0.71 13.80
Fund with Sales Charge (%) (POP) After Shares Sold 18.11 6.35 1.39 12.51

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 02/29/2020 Updated Monthly, based on a 3-year period

Beta 1.04
Sharpe Ratio 0.12
Standard Deviation 22.14

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index